Synthetic cannabinoid exposures reported to texas poison centers

Mathias B. Forrester, Kurt Kleinschmidt, Evan Schwarz, Amy Young

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Synthetic cannabinoid abuse is increasing in the United States. Synthetic cannabinoid exposures reported to Texas poison centers in 2010 were identified, and the distribution of exposures by selected factors was determined. There were 464 total cases. The number of exposures increased each month during January-July, then remained relatively constant for the next 5 months. The patients were 73.9% male and 57.3% were 20 years or older. Moderate or major effects or potentially toxic outcome occurred in 59.9% of the exposures. The most frequently reported clinical effects were tachycardia (37.3%), agitation (18.5%), drowsiness (18.5%), vomiting (15.7%), hallucinations (10.8%), and nausea (9.9%).

Original languageEnglish (US)
Pages (from-to)351-358
Number of pages8
JournalJournal of Addictive Diseases
Volume30
Issue number4
DOIs
StatePublished - 2011

Fingerprint

Cannabinoids
Poisons
Sleep Stages
Hallucinations
Tachycardia
Nausea
Vomiting

Keywords

  • Marijuana homolog
  • Poison center
  • Synthetic cannabinoid

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Synthetic cannabinoid exposures reported to texas poison centers. / Forrester, Mathias B.; Kleinschmidt, Kurt; Schwarz, Evan; Young, Amy.

In: Journal of Addictive Diseases, Vol. 30, No. 4, 2011, p. 351-358.

Research output: Contribution to journalArticle

@article{6dc2be539404411c89a24ca2ca2d7d6b,
title = "Synthetic cannabinoid exposures reported to texas poison centers",
abstract = "Synthetic cannabinoid abuse is increasing in the United States. Synthetic cannabinoid exposures reported to Texas poison centers in 2010 were identified, and the distribution of exposures by selected factors was determined. There were 464 total cases. The number of exposures increased each month during January-July, then remained relatively constant for the next 5 months. The patients were 73.9{\%} male and 57.3{\%} were 20 years or older. Moderate or major effects or potentially toxic outcome occurred in 59.9{\%} of the exposures. The most frequently reported clinical effects were tachycardia (37.3{\%}), agitation (18.5{\%}), drowsiness (18.5{\%}), vomiting (15.7{\%}), hallucinations (10.8{\%}), and nausea (9.9{\%}).",
keywords = "Marijuana homolog, Poison center, Synthetic cannabinoid",
author = "Forrester, {Mathias B.} and Kurt Kleinschmidt and Evan Schwarz and Amy Young",
year = "2011",
doi = "10.1080/10550887.2011.609807",
language = "English (US)",
volume = "30",
pages = "351--358",
journal = "Journal of Addictive Diseases",
issn = "1055-0887",
publisher = "Routledge",
number = "4",

}

TY - JOUR

T1 - Synthetic cannabinoid exposures reported to texas poison centers

AU - Forrester, Mathias B.

AU - Kleinschmidt, Kurt

AU - Schwarz, Evan

AU - Young, Amy

PY - 2011

Y1 - 2011

N2 - Synthetic cannabinoid abuse is increasing in the United States. Synthetic cannabinoid exposures reported to Texas poison centers in 2010 were identified, and the distribution of exposures by selected factors was determined. There were 464 total cases. The number of exposures increased each month during January-July, then remained relatively constant for the next 5 months. The patients were 73.9% male and 57.3% were 20 years or older. Moderate or major effects or potentially toxic outcome occurred in 59.9% of the exposures. The most frequently reported clinical effects were tachycardia (37.3%), agitation (18.5%), drowsiness (18.5%), vomiting (15.7%), hallucinations (10.8%), and nausea (9.9%).

AB - Synthetic cannabinoid abuse is increasing in the United States. Synthetic cannabinoid exposures reported to Texas poison centers in 2010 were identified, and the distribution of exposures by selected factors was determined. There were 464 total cases. The number of exposures increased each month during January-July, then remained relatively constant for the next 5 months. The patients were 73.9% male and 57.3% were 20 years or older. Moderate or major effects or potentially toxic outcome occurred in 59.9% of the exposures. The most frequently reported clinical effects were tachycardia (37.3%), agitation (18.5%), drowsiness (18.5%), vomiting (15.7%), hallucinations (10.8%), and nausea (9.9%).

KW - Marijuana homolog

KW - Poison center

KW - Synthetic cannabinoid

UR - http://www.scopus.com/inward/record.url?scp=84855756474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855756474&partnerID=8YFLogxK

U2 - 10.1080/10550887.2011.609807

DO - 10.1080/10550887.2011.609807

M3 - Article

C2 - 22026527

AN - SCOPUS:84855756474

VL - 30

SP - 351

EP - 358

JO - Journal of Addictive Diseases

JF - Journal of Addictive Diseases

SN - 1055-0887

IS - 4

ER -